Putting The Spotlight On Neuronetics Inc (STIM)

Neuronetics Inc (NASDAQ:STIM) currently has a daily average trading volume of 1.53M but it saw 300265 shares traded in last market. With a market cap of 247.46M USD, the company’s current market price of $3.76 came falling about -0.27 while comparing to the previous closing price of $3.77. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.92 and as low as $0.52. In the recent trading on the day, stock has struck highest price mark of $3.63 while lowest mark touched by it was $3.8195.

Taking a look at 20-day trading activity of Neuronetics Inc (STIM) gives us an average price of $3.89, while its current price level is -36.49% below from 52-week high level whereas it is 623.08% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.24 while that of 200 days or SMA-200 reads an average of $2.08. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.53% during that period while stretching the period over a month that increases to 10.66%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.71 which implies that the stock is in neutral territory.

Over the week, STIM’s stock price is moving -0.27% down while it is -24.95% when we observe its performance for the past one month. Year-to-date it is 133.54% up and over the past year, the stock is showing a downside performance of -6.93%.

The company is expected to be releasing its next quarterly report on 2025-Mar-03, for which analysts forecasted an EPS of -0.12 while estimate for next year EPS is -0.3. In next quarter, company is expected to be making quarterly sales of $36.69M as analysts are expecting the sales for current fiscal year at $148.57M and seeing the company making $163.17M in sales next year. Moreover, analysts are in estimates of $29.07M for current-quarter revenue.

Currently, Neuronetics Inc’s total number of outstanding shares is 55.68M. Company’s return on investment (ROI) stands at -40.93% and return on equity (ROE) at -139.60%. Stock’s beta reads 1.89. Stock has a price to book (P/B) ratio of 7.56 while price to sale or P/S ratio amounts to 3.30. Its return on asset (ROA) is -33.66% on average.